Sarepta Therapeutics (SRPT) Revenue Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 200.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200.22% |
| Dec 31, 2025 | -32.73% |
| Sep 30, 2025 | -14.52% |
| Jun 30, 2025 | 68.38% |
| Mar 31, 2025 | -67.75% |
| Dec 31, 2024 | 42.04% |
| Sep 30, 2024 | 40.79% |
| Jun 30, 2024 | 1,531.15% |
| Mar 31, 2024 | 63.10% |
| Dec 31, 2023 | 173.98% |
| Sep 30, 2023 | 59.70% |
| Jun 30, 2023 | -89.46% |
| Mar 31, 2023 | 1,052.01% |
| Dec 31, 2022 | 51.09% |
| Sep 30, 2022 | 9.70% |
| Jun 30, 2022 | 48.90% |
| Mar 31, 2022 | -85.02% |
| Dec 31, 2021 | 397.80% |
| Sep 30, 2021 | 741.99% |
| Jun 30, 2021 | 445.14% |
| Mar 31, 2021 | 1,010.93% |
| Dec 31, 2020 | -77.53% |
| Sep 30, 2020 | -77.29% |
| Jun 30, 2020 | -72.52% |
| Mar 31, 2020 | -84.80% |
| Dec 31, 2019 | 18.60% |
| Sep 30, 2019 | 26.19% |
| Jun 30, 2019 | 28.75% |
| Mar 31, 2019 | 34.68% |
| Dec 31, 2018 | 47.38% |
| Sep 30, 2018 | 70.79% |
| Jun 30, 2018 | 110.02% |
| Mar 31, 2018 | 295.32% |
| Dec 31, 2014 | -98.97% |
| Sep 30, 2014 | -74.59% |
| Jun 30, 2014 | -12.47% |
| Mar 31, 2014 | 36.08% |
| Dec 31, 2013 | -64.20% |
| Sep 30, 2013 | -44.97% |
| Jun 30, 2013 | -73.67% |
| Mar 31, 2013 | -60.10% |